Martha Shadan - Dec 12, 2024 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ John Pitfield
Stock symbol
LMAT
Transactions as of
Dec 12, 2024
Transactions value $
$0
Form type
4
Date filed
12/13/2024, 05:54 PM
Previous filing
Dec 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +3 +0.17% $0.00 1.73K Dec 12, 2024 Direct F1
transaction LMAT Common Stock Options Exercise $0 +3 +0.17% $0.00 1.73K Dec 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -3 -36.95% $0.00 5.12 Dec 12, 2024 Common Stock 3 Direct F2
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -3 -42.08% $0.00 4.13 Dec 12, 2024 Common Stock 3 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.